PROMUNEL® (Standardized Propolis for Upper Respiratory — PLT Health)

Apis mellifera (propolis)
Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Promunel is a poplar-type propolis extract made in Italy by B Natural with its patented Multi-Dynamic Extraction (M.E.D.) process and sold in North America by PLT Health Solutions. It is standardized to six polyphenols chosen for antimicrobial activity in lab tests. The main efficacy evidence is one randomized, double-blind, placebo-controlled trial in 122 adults with mild upper respiratory symptoms. A throat spray made with the extract (12 to 24 mg polyphenols a day for 5 days) cleared symptoms by day 3 in 83 percent of users, about two days sooner than placebo. One author worked for the extract maker, and the trial tested a spray, not a capsule. A 400 mg oral dose has been studied only for absorption, and a 12-week trial of a poplar propolis extract in 309 adults that tracked respiratory infections is registered as completed, but no peer-reviewed results have been published.

Studied Dose Throat spray: 2 to 4 sprays three times a day (12 to 24 mg polyphenols a day) for 5 days. Oral extract: single 400 mg and 1,600 mg doses, tested for absorption only.
Active Compound Poplar-type propolis extract standardized to six polyphenols. The throat spray in the main trial held 15 mg polyphenols per mL.

Benefits

Upper respiratory comfort in a 5-day throat spray trial

In a placebo-controlled trial of 122 adults with mild upper respiratory symptoms, 83 percent of those using a propolis throat spray (12 to 24 mg polyphenols a day) were symptom-free after 3 days, while 72 percent on placebo still had at least one symptom. This is a single trial, and one author worked for the extract maker.

Throat and upper airway comfort returned sooner than with placebo

By day 5 everyone in the trial had recovered, so the gain was speed: symptoms in the propolis group cleared about two days sooner than with placebo. No adverse reactions were linked to the spray. The product was sprayed into the throat, so the result may not carry over to a swallowed capsule.

Standardized to six polyphenols

Each batch is standardized to six polyphenols, so the amount of these compounds per dose is defined. The spray used in the trial contained 15 mg polyphenols per mL. Standardization describes the product's makeup; it does not by itself show a health effect.

Antimicrobial activity in laboratory tests

The six polyphenols were selected for antimicrobial activity in laboratory tests. Activity in a lab dish does not show what happens in the body, and no human study has tested Promunel against a specific germ.

Polyphenols absorbed and cleared within hours

In 10 healthy adults, polyphenol metabolites from a 400 mg dose peaked in blood after about 1 hour and were mostly excreted in urine within 3 hours, with about 57 percent of the polyphenols absorbed. Half of the researchers, including the lead and senior authors, work for Fytexia, a company with an ownership stake in the extract maker B Natural, and they suggested taking it more than once a day.

Mechanism of action

1

Polyphenol antimicrobial activity (lab data)

Propolis polyphenols such as those Promunel is standardized to show antimicrobial activity in laboratory tests. This lab activity is the basis for the product's design, not a demonstrated effect in people.

2

Direct contact with the throat

The trial product was a spray applied to the throat three times a day, so any benefit may come from local contact with throat tissue. Whether a swallowed capsule acts the same way has not been tested.

3

Fast absorption and short time in the blood

After a 400 mg dose, blood levels of propolis polyphenol metabolites, mainly glucuronides and sulfates, peaked within about an hour and fell over the following hours as they were cleared in urine. A single daily dose therefore gives only a short window of exposure.

4

Multi-Dynamic Extraction (M.E.D.) process

B Natural's patented M.E.D. process extracts and concentrates the polyphenols from raw propolis to a set specification. It is a manufacturing method; no trial has compared it with other extraction methods.

Clinical trials

1
Propolis throat spray for mild upper respiratory symptoms
PubMed

Single-center, randomized, double-blind, placebo-controlled trial of an oral throat spray made with a standardized poplar-type propolis extract (15 mg polyphenols per mL), 2 to 4 sprays three times a day (12 to 24 mg polyphenols a day) for 5 days, with visits at day 3, day 5 and a 15-day follow-up. One author was from the extract maker B Natural. (Esposito et al. 2021, Phytomedicine)

122 otherwise healthy adults who reported mild, uncomplicated upper respiratory symptoms (58 propolis, 64 placebo).

After 3 days, 83 percent of the propolis group had no symptoms, while 72 percent of the placebo group still had at least one. By day 5 all participants had recovered, so symptoms resolved about two days sooner with propolis. No adverse reactions were linked to the spray or placebo. The product was a throat spray, not a capsule.

2
Promunel absorption study (400 mg and 1,600 mg doses)
PubMed

Double-blind, randomized, placebo-controlled crossover study measuring blood and urine polyphenol metabolites for 48 hours after single 400 mg and 1,600 mg doses of Promunel. Half the authors, including the first and last, worked for Fytexia, which holds a stake in the extract maker B Natural. (Jaffrelo et al. 2026, Food Funct)

10 healthy adults.

The researchers identified 63 polyphenol metabolites in plasma and 85 in urine, mostly glucuronides and sulfates. Plasma levels peaked about 1 hour after intake and urinary excretion was mostly complete within 3 hours. About 57 percent of the polyphenols were absorbed at 400 mg and 44 percent at 1,600 mg. This study measured absorption only, not any health outcome.

Side effects and drug interactions

Common Potential side effects

No adverse reactions were linked to the propolis throat spray in the 122-person trial.
Bee product allergy: avoid if you are allergic to propolis, royal jelly, honey or bee venom.
People with asthma and a bee product sensitivity should ask a clinician before use.
Long-term safety of Promunel has not been studied; its published human studies lasted 5 days (throat spray) or a single dose (absorption study).
Pregnancy and lactation: supplemental propolis has not been studied; ask a clinician first.

Important Drug interactions

Bee product allergy: avoid if you react to any bee product, since cross-reactions between bee products are possible.
Warfarin: no human study has tested propolis with warfarin. In one mouse study propolis weakened warfarin's effect (lower INR). If you take warfarin, ask your anticoagulation clinic before starting.
Other prescription drugs: in 16 healthy adults, a Brazilian green propolis extract (375 mg a day for 15 days) changed blood levels of six test drugs by less than 20 percent. That extract is not Promunel, and warfarin was not tested.
Immunosuppressants: not studied with propolis. If you take transplant or autoimmune medicines, check with your prescriber first.
Pregnancy and lactation: ask a clinician before using supplemental doses.
Children: check for bee product allergy before first use in young children.

Frequently asked questions about PROMUNEL® (Standardized Propolis for Upper Respiratory — PLT Health)

What is PROMUNEL?

Promunel is a poplar-type propolis extract made in Italy by B Natural with its patented Multi-Dynamic Extraction (M.E.D.) process and sold in North America by PLT Health Solutions. It is standardized to six polyphenols chosen for antimicrobial activity in lab tests.

What is PROMUNEL used for?

PROMUNEL is researched primarily for Immune Support and Respiratory Health. In a placebo-controlled trial of 122 adults with mild upper respiratory symptoms, 83 percent of those using a propolis throat spray (12 to 24 mg polyphenols a day) were symptom-free after 3 days, while 72 percent on placebo still had at lea…

What is the recommended dosage of PROMUNEL?

The clinically studied dose is Throat spray: 2 to 4 sprays three times a day (12 to 24 mg polyphenols a day) for 5 days. Oral extract: single 400 mg and 1,600 mg doses, tested for absorption only. Always follow the product label and check with a healthcare provider for personal advice.

Is PROMUNEL safe, and does it have side effects?

Side effects and cautions reported for PROMUNEL include: No adverse reactions were linked to the propolis throat spray in the 122-person trial. Bee product allergy: avoid if you are allergic to propolis, royal jelly, honey or bee venom. It may also interact with some medications. PROMUNEL is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does PROMUNEL interact with any medications?

Possible interactions include: Bee product allergy: avoid if you react to any bee product, since cross-reactions between bee products are possible. Warfarin: no human study has tested propolis with warfarin. In one mouse study propolis weakened warfarin's effect (lower INR). If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for PROMUNEL?

NutraSmarts rates the evidence for PROMUNEL as Limited (2 out of 5). It is backed by 2 study summaries and 9 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(9 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Esposito C, Garzarella EU, Bocchino B, D'Avino M, Caruso G, Buonomo AR, Sacchi R, Galeotti F, Tenore GC, Zaccaria V, Daglia M. A standardized polyphenol mixture extracted from poplar-type propolis for remission of symptoms of uncomplicated upper respiratory tract infection (URTI): A monocentric, randomized, double-blind, placebo-controlled clinical trial. Phytomedicine. 2021;80:153368. doi: 10.1016/j.phymed.2020.153368.PubMedUsed to support: Randomized, double-blind, placebo-controlled trial in 122 adults with mild uncomplicated upper respiratory symptoms. An oral throat spray of standardized poplar-type propolis extract (12 to 24 mg polyphenols a day for 5 days) gave symptom remission by day 3 in 83 percent of users, while 72 percent on placebo still had a symptom; all participants recovered by day 5. No adverse reactions were linked to treatment. The product was a spray, not a capsule, and one author (Zaccaria V) was from B Natural, the extract maker.
  2. Jaffrelo M, Iglesias-Carres L, Raymond C, Del Pino A, Salinas-Camargo JC, Chung LH, Alcaraz PE, Canela N, Romain C, Cases J. Nutrikinetics and bioavailability of Promunel®, a standardized poplar-type propolis phenolic extract: a double-blinded, placebo-controlled, cross-over, randomized trial. Food Funct. 2026;17(17):7687-7700. doi: 10.1039/d6fo00175k.PubMedUsed to support: Crossover absorption study in 10 healthy adults given single 400 mg and 1,600 mg doses of Promunel. Polyphenol metabolites, mostly glucuronides and sulfates, peaked in plasma about 1 hour after intake and were mostly excreted in urine within 3 hours. Net absorption was about 57 percent at 400 mg and 44 percent at 1,600 mg. Half the authors, including the first and last, work for Fytexia, which holds a stake in the extract maker B Natural. No health outcome was measured.
  3. Fytexia. Poplar-type Propolis Dry Extract ESIT12: Immunomodulation Efficacy Study (NCT05598749). ClinicalTrials.gov. 2024;Registry record NCT05598749, last updated 2024-09-25..SourceUsed to support: Registry record, not PubMed-indexed. A double-blind, randomized, placebo-controlled trial sponsored by Fytexia testing a poplar-type propolis dry extract (ESIT12) for 12 weeks in adults aged 25 to 69 at risk of upper respiratory infections, with infection incidence as the primary outcome. 309 participants were enrolled and the trial was completed on 2024-07-03, but no results are posted and no peer-reviewed results paper was found. Fytexia has described results from a 12-week study of 400 mg a day in 295 adults in trade press, but without a published paper those figures cannot be checked.
  4. Cusinato DAC, Martinez EZ, Cintra MTC, Filgueira GCO, Berretta AA, Lanchote VL, Coelho EB. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach. J Ethnopharmacol. 2019;245:112174. doi: 10.1016/j.jep.2019.112174.PubMedUsed to support: Drug interaction study in 16 healthy adults who took a Brazilian green propolis extract (375 mg a day) for 15 days. Blood levels of caffeine, losartan, omeprazole, metoprolol, midazolam and fexofenadine changed by less than 20 percent, which the authors judged not clinically relevant. Warfarin was not tested, the extract is not Promunel, and one author works for the extract maker Apis Flora.
  5. Akbay E, Özenirler Ç, Çelemli ÖG, Durukan AB, Onur MA, Sorkun K. Effects of propolis on warfarin efficacy. Kardiochir Torakochirurgia Pol. 2017;14(1):43-46. doi: 10.5114/kitp.2017.66929.PubMedUsed to support: Mouse study in which propolis given with warfarin lowered the INR compared with warfarin alone, meaning propolis weakened warfarin's anticoagulant effect. The authors called for awareness of a possible interaction. This is an animal study; no human study has tested propolis with warfarin.
  6. Silveira MAD, De Jong D, Berretta AA, Galvão EBDS, Ribeiro JC, Cerqueira-Silva T, Amorim TC, Conceição LFMRD, Gomes MMD, Teixeira MB, Souza SP, Santos MHCAD, San Martin RLA, Silva MO, Lírio M, Moreno L, Sampaio JCM, Mendonça R, Ultchak SS, Amorim FS, Ramos JGR, Batista PBP, Guarda SNFD, Mendes AVA, Passos RDH, BeeCovid Team. Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial. Biomed Pharmacother. 2021;138:111526. doi: 10.1016/j.biopha.2021.111526.PubMedUsed to support: Open-label randomized trial in 124 hospitalized COVID-19 patients given standard care plus 400 or 800 mg a day of Brazilian green propolis for 7 days, or standard care alone. Hospital stay after the intervention was shorter in both propolis groups (median 7 and 6 days versus 12). Oxygen need did not differ. Acute kidney injury was lower only in the 800 mg group (4.8 versus 23.8 percent). One author is employed by the extract maker Apis Flora. This is a different propolis type, not Promunel.
  7. Silveira MAD, Menezes MA, de Souza SP, Galvão EBDS, Berretta AA, Caldas J, Teixeira MB, Gomes MMD, Damiani LP, Bahiense BA, Cabral JB, De Oliveira CWLM, Mascarenhas TR, Pinheiro PCG, Alves MS, de Melo RMV, Leite FM, Nonaka CKV, Souza BSF, Baptista NU, Teles F, da Guarda SF, Mendes AVA, Passos RDH. Standardized Brazilian green propolis extract (EPP-AF®) in COVID-19 outcomes: a randomized double-blind placebo-controlled trial. Sci Rep. 2023;13(1):18405. doi: 10.1038/s41598-023-43764-w.PubMedUsed to support: Double-blind, placebo-controlled trial in 188 hospitalized COVID-19 patients given 900 mg a day of Brazilian green propolis or placebo for 10 days. Length of hospital stay, the primary outcome, did not differ significantly, nor did oxygen need or acute kidney injury. Secondary infections were less frequent with propolis (6.1 versus 18.9 percent). This is a different propolis type, not Promunel.
  8. PLT Health Solutions. PROMUNEL® Ultra-Performance Propolis (product page). plthealth.com. 2026;.SourceUsed to support: Supplier page stating that the extract is made with M.E.D., an extraction technology developed and patented by B Natural, and standardized to six polyphenols (chrysin, galangin, pinocembrin, apigenin, pinobanksin and quercetin). It also describes a 12-week, 400 mg a day study in 295 adults that has not been published in a peer-reviewed journal, so those figures cannot be checked. Not PubMed-indexed.
  9. NutraIngredients. Fytexia and B Natural creating a buzz for propolis. nutraingredients.com. 2021;Published 27 May 2021..SourceUsed to support: Trade press report that Fytexia signed an equity partnership with the Italian propolis producer B Natural, making a strategic investment in the company. Not PubMed-indexed.